Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome

被引:27
|
作者
Saad, F. [1 ,2 ]
Gooren, L. [3 ]
Haider, A.
Yassin, A. [2 ,4 ]
机构
[1] Bayer Scherning, Dept Mens Hlthcare, D-13342 Berlin, Germany
[2] Gulf Med Coll, Sch Med, Ajman, U Arab Emirates
[3] VUmc, Amsterdam, Netherlands
[4] Segeberger Klin, Dept Urol, Norderstedt, Germany
关键词
ageing; metabolic syndrome; sexual functioning; testosterone gel; testosterone undecanoate;
D O I
10.1111/j.1439-0272.2008.00807.x
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The effects of administration of testosterone (T) gel, resulting in plasma T levels in the low range of reference values, followed by testosterone undecanoate (TU), producing plasma T levels in the mid-normal range, were measured in 27 hypogonadal men aged 47-74 years. T gel had positive effects on the International Index of Erectile Function, the Aging Males' Symptoms Scale and International Prostate Symptoms Score and on the metabolic syndrome. The improvement was larger when TU was administered and plasma T levels were higher. The reduction in waist circumference and plasma cholesterol were larger with TU than with T gel, while the increases in plasma high-density lipoprotein and sex hormone binding globulin (an indicator of the severity of the metabolic syndrome) were larger with TU than with T gel. Both T gel and TU appeared safe on prostate parameters. Plasma haemoglobin and haematocrit were elevated but remained in the normal range. The assumption that treatment with T is adequate when achieved plasma levels of T are within the reference range is no longer tenable. Some androgen-dependent biological functions require higher plasma T levels than others, and, moreover, these thresholds differ among men.
引用
收藏
页码:44 / 48
页数:5
相关论文
共 50 条
  • [1] A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate
    Saad, Farid
    Gooren, Louis J.
    Haider, Ahmad
    Yassin, Aksam
    JOURNAL OF ANDROLOGY, 2008, 29 (01): : 102 - 105
  • [2] Testosterone undecanoate effects on cardiovascular risk factors in men with metabolic syndrome
    Vertkin, A. L.
    Naumov, A. V.
    Morgunov, L. Yu.
    Kalinchenko, S. Yu.
    Krivtsova, E. V.
    Arinina, E. N.
    Kolosova, E. S.
    Plupanova, Yu. S.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (05): : 68 - 75
  • [3] EFFECT OF THE LONG-ACTING PARENTERAL TESTOSTERONE UNDECANOATE IN ERECTILE DYSFUNCTION
    Kim, Joon Yong
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 269 - 269
  • [4] Effects of Testosterone Supplementation on Depressive Symptoms and Sexual Dysfunction in Hypogonadal Men with the Metabolic Syndrome
    Giltay, Erik J.
    Tishova, Yuliya A.
    Mskhalaya, George J.
    Gooren, Louis J. G.
    Saad, Farid
    Kalinchenko, Svetlana Y.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (07): : 2572 - 2582
  • [5] THE MOSCOW STUDY A RANDOMIZED PLACEBO CONTROLLED DOUBLE BLIND TRIAL OF PARENTERAL TESTOSTERONE UNDECANOATE ON THE METABOLIC SYNDROME AND INFLAMMATION
    Tishova, Y. A.
    Mskhalaya, G. Z.
    Saad, F.
    Gooren, Louis J. G.
    Kalinchenko, S. Y.
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 257 - 257
  • [6] The Efficacy of Combination Treatment with Injectable Testosterone Undecanoate and Daily Tadalafil for Erectile Dysfunction with Testosterone Deficiency Syndrome
    Park, Min Gu
    Yeo, Jeong Kyun
    Cho, Dae-Yeon
    Kim, Jin Wook
    Kim, Jong Wook
    Oh, Mi Mi
    Kim, Je Jong
    Moon, Du Geon
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 (04): : 966 - 974
  • [7] Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome
    Francomano, Davide
    Lenzi, Andrea
    Aversa, Antonio
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [8] COMPARATIVE STUDY IN FM TRANSSEXUALS' TREATMENTS: CONVENTIONAL TESTOSTERONE VS. PARENTERAL TESTOSTERONE UNDECANOATE
    Carrasco, R.
    Almaraz, M. C.
    Haro-Mora, J.
    Yahyaoui, R.
    Martinez-Tudela, J.
    Gomez-Gil, E.
    Fernandez, R.
    Maldonado, C.
    Olveira, G.
    Casimiro-Soriguer, F.
    Esteva, I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 54 - 54
  • [9] Effects of testosterone undecanoate as a male contraceptive candidate on rat immunological features
    Yu, MC
    Cao, XM
    Xu, JJ
    Wang, XL
    Yang, J
    Wang, XH
    Ben, KL
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2003, 25 (04) : 627 - 643
  • [10] Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido®)
    Aksam A. Yassin
    Farid Saad
    World Journal of Urology, 2006, 24 : 639 - 644